{"id":"https://openalex.org/W2189501544","doi":null,"title":"Research Article Drug Interaction of Repaglinide and Mangiferin in Rats","display_name":"Research Article Drug Interaction of Repaglinide and Mangiferin in Rats","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W2189501544","mag":"2189501544"},"language":"en","primary_location":{"id":"mag:2189501544","doi":null,"is_oa":false,"landing_page_url":"http://ijpcsonline.com/files/11-554.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041605753","display_name":"Sekhar H. S","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sekhar Hs","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110507496","display_name":"Kiran Nagaraj","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Nagaraj","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072066565","display_name":"Burri Nagaraju","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Burri Nagaraju","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5076887518","display_name":"Hossein Nemati","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hossein Nemati","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13846","display_name":"Mangiferin and Mango Extracts","score":0.9526000022888184,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13846","display_name":"Mangiferin and Mango Extracts","score":0.9526000022888184,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies","score":0.04170000180602074,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/repaglinide","display_name":"repaglinide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/mangiferin","display_name":"mangiferin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8519999980926514},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9319999814033508},{"id":"https://openalex.org/keywords/herbal-antidiabetic-agents","display_name":"herbal antidiabetic agents","score":0.6679999828338623},{"id":"https://openalex.org/keywords/alpha-glucosidase-inhibition","display_name":"\u03b1-glucosidase inhibition","score":0.7929999828338623},{"id":"https://openalex.org/keywords/cyp3a4-inhibition","display_name":"CYP3A4 inhibition","score":0.9330000281333923},{"id":"https://openalex.org/keywords/atp-sensitive-potassium-channels","display_name":"ATP-sensitive potassium channels","score":0.6639999747276306},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.746999979019165},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.8830000162124634},{"id":"https://openalex.org/keywords/alloxan-induced-diabetes","display_name":"alloxan-induced diabetes","score":0.9399999976158142},{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":0.7059999704360962},{"id":"https://openalex.org/keywords/ayurveda","display_name":"Ayurveda","score":0.7699999809265137}],"concepts":[{"id":"https://openalex.org/C2777781930","wikidata":"https://www.wikidata.org/wiki/Q1074417","display_name":"Mangiferin","level":2,"score":0.9475594758987427},{"id":"https://openalex.org/C2781281211","wikidata":"https://www.wikidata.org/wiki/Q2195995","display_name":"Repaglinide","level":4,"score":0.9017438292503357},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.634820818901062},{"id":"https://openalex.org/C2780548744","wikidata":"https://www.wikidata.org/wiki/Q416584","display_name":"Nitrendipine","level":3,"score":0.5948307514190674},{"id":"https://openalex.org/C2779768347","wikidata":"https://www.wikidata.org/wiki/Q420626","display_name":"Glibenclamide","level":3,"score":0.5614052414894104},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5595648288726807},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5329291224479675},{"id":"https://openalex.org/C2777448766","wikidata":"https://www.wikidata.org/wiki/Q290001","display_name":"Gliclazide","level":3,"score":0.5119863152503967},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4731627106666565},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.469498872756958},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44794440269470215},{"id":"https://openalex.org/C2781005915","wikidata":"https://www.wikidata.org/wiki/Q417701","display_name":"Alloxan","level":3,"score":0.44704699516296387},{"id":"https://openalex.org/C2780485761","wikidata":"https://www.wikidata.org/wiki/Q275157","display_name":"Blood sugar","level":3,"score":0.42643940448760986},{"id":"https://openalex.org/C2776054734","wikidata":"https://www.wikidata.org/wiki/Q414275","display_name":"Tolbutamide","level":3,"score":0.4185764491558075},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3388603925704956},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.3098023533821106},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.254569947719574}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2189501544","doi":null,"is_oa":false,"landing_page_url":"http://ijpcsonline.com/files/11-554.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1596948422","https://openalex.org/W1972193133","https://openalex.org/W1976717028","https://openalex.org/W1982161177","https://openalex.org/W1982636837","https://openalex.org/W1984824289","https://openalex.org/W1991771156","https://openalex.org/W2000651819","https://openalex.org/W2011225986","https://openalex.org/W2011377138","https://openalex.org/W2019481966","https://openalex.org/W2026714880","https://openalex.org/W2029337212","https://openalex.org/W2034402249","https://openalex.org/W2034448197","https://openalex.org/W2037330345","https://openalex.org/W2047057122","https://openalex.org/W2058016732","https://openalex.org/W2090745121","https://openalex.org/W2110401218","https://openalex.org/W2129212470","https://openalex.org/W2468825568","https://openalex.org/W2742803912"],"related_works":["https://openalex.org/W2923050913","https://openalex.org/W1137897295","https://openalex.org/W2088281471","https://openalex.org/W2091099367","https://openalex.org/W2069390464","https://openalex.org/W117036917","https://openalex.org/W7201868411","https://openalex.org/W1970517294","https://openalex.org/W2062384175","https://openalex.org/W2779247674"],"abstract_inverted_index":{"Herbal":[0],"antidiabetic":[1],"preparations":[2],"are":[3],"often":[4],"used":[5,25,62,276],"as":[6,142,186],"an":[7,69],"add-on":[8],"therapy":[9],"in":[10,27,82,115,148,189,205,250],"diabetics.":[11],"Mangiferin":[12,22,34,171,238,271],"indica":[13],"(Anacardiaceae)":[14],"stem":[15],"bark":[16],"contains":[17],"a":[18,57,83,90,143],"rich":[19],"content":[20],"of":[21,48,60,78,102,118,180,199,243,270],"and":[23,132,140,164,177,218,225,237,245,249,272],"is":[24,56,152,168,183],"traditionally":[26],"Indian":[28],"Ayurvedic":[29],"system":[30],"to":[31,38,68,86,262,265],"treat":[32,63],"diabetes.":[33],"has":[35,261],"been":[36],"reported":[37],"be":[39,263],"potent":[40],"Alpha-":[41],"Glucosidase":[42],"inhibitor":[43],"that":[44,51,170,257],"also":[45],"shows":[46],"modulation":[47],"CYP450":[49],"enzyme":[50],"inhibits":[52],"CYP3A4":[53,163],"enzyme.":[54],"Repaglinide":[55,181,273],"Meglitinides,":[58],"class":[59],"drugs":[61],"diabetes":[64],"type":[65],"2.They":[66],"bind":[67],"ATP-dependent":[70,112],"K+":[71],"(KATP)":[72],"channel":[73],"on":[74],"the":[75,100,105,116,119,124,128,133,174,241,267],"cell":[76],"membrane":[77,117],"pancreatic":[79],"beta":[80,120,125],"cells":[81],"similar":[84],"manner":[85],"sulfonylureas":[87],"but":[88],"at":[89],"separate":[91],"binding":[92],"site.":[93],"It":[94,107,151],"lowers":[95],"blood":[96,211,220],"glucose":[97],"by":[98,110,154,161],"stimulating":[99],"release":[101],"insulin":[103,138],"from":[104,215],"pancreas.":[106],"achieves":[108],"this":[109],"closing":[111],"potassium":[113],"channels":[114],"cells.":[121],"This":[122],"depolarizes":[123],"cells,":[126],"opening":[127],"cells'":[129],"calcium":[130,135],"channels,":[131],"resulting":[134],"influx":[136],"induces":[137],"secretion.":[139],"emerged":[141],"novel":[144],"oral":[145],"Antidiabetic":[146],"agent":[147],"recent":[149],"past.":[150],"metabolised":[153],"multiple":[155],"Cytochrome":[156],"P450":[157],"(CYP)":[158],"isoenzymes,":[159],"mainly":[160],"CYP2C8,":[162],"CYP2C9.":[165],"Hence":[166],"it":[167],"speculated":[169],"may":[172,193],"influence":[173],"kinetic,":[175],"diabetic":[176,208,216],"Hepatotoxicity":[178,231,233],"effect":[179],"which":[182],"particularly":[184],"crucial,":[185],"any":[187],"increment":[188],"its":[190],"plasma":[191],"level":[192,242],"raise":[194],"safety":[195],"concerns.":[196],"Lipid":[197],"profile":[198],"Repaglinide(0.2mg/kg)":[200],"with":[201,230,252],"Mangiferin(200mg/kg)":[202],"were":[203,213],"evaluated":[204],"Alloxan":[206],"induced":[207],"rats.":[209],"The":[210,254],"samples":[212],"collected":[214],"rats":[217],"Fasting":[219],"sugar,":[221],"TG,":[222],"TC,":[223],"LDL":[224],"HDL":[226],"was":[227,235],"estimated":[228,236],"along":[229],"study.":[232],"activity":[234],"significantly":[239],"reduces":[240],"AST":[244],"ALT":[246],"enzymes":[247],"alone":[248],"combination":[251],"Repaglinide.":[253],"study":[255],"indicates":[256],"Therapeutic":[258],"drug":[259],"monitoring":[260],"required":[264],"readjust":[266],"therapeutic":[268],"dose":[269],"when":[274],"they":[275],"concomitantly.":[277]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}